Current Constructs and Targets in Clinical Development for Antibody- Based Cancer Therapy

E-ISSN： 1873-5592|10|2|158-175

ISSN： 1389-4501

Source： Current Drug Targets, Vol.10, Iss.2, 2009-02, pp. : 158-175

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibody-based cancer therapy

By Baxevanis Constantin N

Expert Opinion on Drug Discovery, Vol. 3, Iss. 4, 2008-04 ,pp. : 441-452

Informa Healthcare

Access to resources Recommend Favorite

Antibody-based antiangiogenic cancer therapy

By Sanz Laura Álvarez-Vallina Luis

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 6, 2005-12 ,pp. : 1235-1245

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal Antibody-Based Targeted Therapy in Breast Cancer: Current Status and Future Directions

By Bernard-Marty Chantal Lebrun Fabienne Awada Ahmad Piccart Martine J.

Drugs, Vol. 66, Iss. 12, 2006-01 ,pp. : 1577-1591

Adis International

Access to resources Recommend Favorite

Small interfering RNA therapy in cancer: mechanism, potential targets, and clinical applications

By Huang Chuan Li Min Chen Changyi Yao Qizhi

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 5, 2008-05 ,pp. : 637-645

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal Antibody-Based Therapy Strategies: Providing Options for the Cancer Patient

Current Pharmaceutical Design, Vol. 8, Iss. 19, 2002-09 ,pp. : 1749-1764

Bentham Science Publishers

Access to resources Recommend Favorite